Search
Close this search box.

November 2024

British and US Diplomats Highlight Cyprus’ Strategic Role in Regional Affairs.

Nicosia: British High Commissioner Designate to the Republic of Cyprus, Michael Tatham, and US Ambassador to Cyprus, Julie Fisher, emphasized Cyprus’ strategic significance in regional matters at the Economist 20th Annual Cyprus Summit on Thursday. Tatham underscored the UK’s appreciation of Cyprus’ role, while Ambassador Fisher commended Cyprus’ initiatives, particularly

Read More

Weak Low Pressure Brings Isolated Showers to Cyprus Sea Area.

Nicosia: The Cyprus Department of Meteorology has issued a forecast for the sea area of Cyprus, indicating that weak low pressure is currently affecting the region. Isolated showers or thunderstorms are anticipated tonight, primarily over the western and northern coastal areas. During storms, winds may vary, becoming strong and gusty,

Read More

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discovery

Read More

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discovery

Read More

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discovery

Read More